Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 2308: Semi-automated Ki-67 index assessment using top-k hotspot recommendation in Ki-67 IHC stained WSIs

View through CrossRef
Abstract Ki-67 index is commonly used as a breast cancer proliferation marker. However, it is a laborious and time-consuming task for a pathologist to directly measure the Ki-67 index. Recently, automation techniques using machine learning techniques such as deep learning have been proposed. In this study, we propose a top-k hotspot recommendation method to help Ki-67 index assessment based on nuclei detection detected by a deep learning model. The dataset included a total of 32 diaminobenzidine-hematoxylin (DAB-H) Ki-67 IHC whole slide images (WSIs) of breast cancer obtained by core biopsy. Each of these WSIs was evaluated by a pathologist using the interval of the Ki-67 index estimate and the scores of 1+, 2+, 3+, and 4+. Additionally, the search area was manually designated to exclude internal control. We developed a Ki-67 index analysis model based on deep learning and image analysis. Nuclei segmentation used the StarDist model. The detected results were filtered based on nucleus size and nucleus eccentricity. The filtering threshold was determined experimentally. To recommend top-k hotspots, a coarse search is performed to move the circle region horizontally and vertically in specific units, and the top k regions based on Ki-67 index are found among areas containing more than 500 cells. Next, a fine search is performed around the k areas in detail. Finally, the top-k hotspots and each detected positive and negative cells, count of positive cells and negative cells, and predicted Ki-67 index are provided. It was confirmed that the Ki-67 score estimated for the detected top-1 hotspot and the pathologist's Ki-67 score had a correlation of Pearson correlation coefficient=0.8153, R2=0.6648. As k increased, the top-k accuracy was observed to increase from 68.75% when k = 1 and 3 to 75.00% when k = 5, based on the pathologist's score. When a pathologist reviewed 10 cases where the Ki-67 score differed from the prediction, 6 cases were judged to be worth reexamining considering the proposed hotspot and Ki-67 index, and 2 cases included stromal cells in cell detection. In two cases, the WSI was judged to be blurry. Cell analysis and top-k hotspot recommendation using deep learning and image analysis were performed on Ki-67 IHC stained WSIs and compared with the pathologist's Ki-67 score. Through semi-automatic top-k hotspot recommendation, the reliability of diagnosis can be increased as an auxiliary test to Ki-67 index assessment. Citation Format: Hyeon Seok Yang, Yunseob Hwang, Yongeun Lee, Kyungsoo Jung, Minjung Sung, Tae-Yeong Kwak, Sun Woo Kim, Hyeyoon Chang. Semi-automated Ki-67 index assessment using top-k hotspot recommendation in Ki-67 IHC stained WSIs [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2308.
Title: Abstract 2308: Semi-automated Ki-67 index assessment using top-k hotspot recommendation in Ki-67 IHC stained WSIs
Description:
Abstract Ki-67 index is commonly used as a breast cancer proliferation marker.
However, it is a laborious and time-consuming task for a pathologist to directly measure the Ki-67 index.
Recently, automation techniques using machine learning techniques such as deep learning have been proposed.
In this study, we propose a top-k hotspot recommendation method to help Ki-67 index assessment based on nuclei detection detected by a deep learning model.
The dataset included a total of 32 diaminobenzidine-hematoxylin (DAB-H) Ki-67 IHC whole slide images (WSIs) of breast cancer obtained by core biopsy.
Each of these WSIs was evaluated by a pathologist using the interval of the Ki-67 index estimate and the scores of 1+, 2+, 3+, and 4+.
Additionally, the search area was manually designated to exclude internal control.
We developed a Ki-67 index analysis model based on deep learning and image analysis.
Nuclei segmentation used the StarDist model.
The detected results were filtered based on nucleus size and nucleus eccentricity.
The filtering threshold was determined experimentally.
To recommend top-k hotspots, a coarse search is performed to move the circle region horizontally and vertically in specific units, and the top k regions based on Ki-67 index are found among areas containing more than 500 cells.
Next, a fine search is performed around the k areas in detail.
Finally, the top-k hotspots and each detected positive and negative cells, count of positive cells and negative cells, and predicted Ki-67 index are provided.
It was confirmed that the Ki-67 score estimated for the detected top-1 hotspot and the pathologist's Ki-67 score had a correlation of Pearson correlation coefficient=0.
8153, R2=0.
6648.
As k increased, the top-k accuracy was observed to increase from 68.
75% when k = 1 and 3 to 75.
00% when k = 5, based on the pathologist's score.
When a pathologist reviewed 10 cases where the Ki-67 score differed from the prediction, 6 cases were judged to be worth reexamining considering the proposed hotspot and Ki-67 index, and 2 cases included stromal cells in cell detection.
In two cases, the WSI was judged to be blurry.
Cell analysis and top-k hotspot recommendation using deep learning and image analysis were performed on Ki-67 IHC stained WSIs and compared with the pathologist's Ki-67 score.
Through semi-automatic top-k hotspot recommendation, the reliability of diagnosis can be increased as an auxiliary test to Ki-67 index assessment.
Citation Format: Hyeon Seok Yang, Yunseob Hwang, Yongeun Lee, Kyungsoo Jung, Minjung Sung, Tae-Yeong Kwak, Sun Woo Kim, Hyeyoon Chang.
Semi-automated Ki-67 index assessment using top-k hotspot recommendation in Ki-67 IHC stained WSIs [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2308.

Related Results

Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract Introduction Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Assessment of HER2 Status of Metastatic Breast Carcinoma on Cell Block Preparations of Fine Needle Aspirates is Unreliable
Assessment of HER2 Status of Metastatic Breast Carcinoma on Cell Block Preparations of Fine Needle Aspirates is Unreliable
Objectives: HER2 status of breast carcinoma is a powerful prognostic and predictive biomarker-particularly in the metastatic setting. Limited data is available regarding assessment...
HER2 in uterine carcinosarcoma: Testing platforms and implications for targeted therapy.
HER2 in uterine carcinosarcoma: Testing platforms and implications for targeted therapy.
5590 Background: Uterine carcinosarcomas (UCS) are rare, aggressive tumors accounting for 5% of all uterine cancers. Recurrence rates are high and 5-year survival is only 18-39%. ...
Assessment of Hormone Receptor Profile in Breast Cancer Using 18F‐Fluro‐Estradiol PET CT: A Pilot Study
Assessment of Hormone Receptor Profile in Breast Cancer Using 18F‐Fluro‐Estradiol PET CT: A Pilot Study
Hormone Receptor (HR) status has vital implications in prognosis and therapy of breast cancer. Currently, HR status is assessed by immunohistochemistry (IHC) of core needle biopsy ...
Tracing hotspot traces in the Andes
Tracing hotspot traces in the Andes
Two segments of subduction of the Nazca plate beneath the South American plate occur at low angles based on seismic hypocenter locations, approaching nearly horizontal below ~100 k...
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
5580 Background: HER2 is an emerging prognostic and therapeutic target in uterine serous carcinoma (USC). Testing algorithms and platforms in breast and gastric cancers are well s...

Back to Top